1. Home
  2. HLIT vs MDXG Comparison

HLIT vs MDXG Comparison

Compare HLIT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLIT
  • MDXG
  • Stock Information
  • Founded
  • HLIT 1988
  • MDXG 2006
  • Country
  • HLIT United States
  • MDXG United States
  • Employees
  • HLIT N/A
  • MDXG N/A
  • Industry
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • HLIT Technology
  • MDXG Health Care
  • Exchange
  • HLIT Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • HLIT 1.0B
  • MDXG 877.4M
  • IPO Year
  • HLIT 1995
  • MDXG N/A
  • Fundamental
  • Price
  • HLIT $8.35
  • MDXG $7.16
  • Analyst Decision
  • HLIT Buy
  • MDXG Strong Buy
  • Analyst Count
  • HLIT 6
  • MDXG 2
  • Target Price
  • HLIT $11.50
  • MDXG $12.00
  • AVG Volume (30 Days)
  • HLIT 1.5M
  • MDXG 1.0M
  • Earning Date
  • HLIT 07-28-2025
  • MDXG 07-30-2025
  • Dividend Yield
  • HLIT N/A
  • MDXG N/A
  • EPS Growth
  • HLIT 17.01
  • MDXG N/A
  • EPS
  • HLIT 0.58
  • MDXG 0.21
  • Revenue
  • HLIT $689,084,000.00
  • MDXG $363,774,000.00
  • Revenue This Year
  • HLIT N/A
  • MDXG $9.55
  • Revenue Next Year
  • HLIT $21.74
  • MDXG $11.43
  • P/E Ratio
  • HLIT $14.42
  • MDXG $33.78
  • Revenue Growth
  • HLIT 24.14
  • MDXG 6.85
  • 52 Week Low
  • HLIT $7.80
  • MDXG $5.47
  • 52 Week High
  • HLIT $15.46
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • HLIT 36.20
  • MDXG 61.08
  • Support Level
  • HLIT $7.80
  • MDXG $6.47
  • Resistance Level
  • HLIT $9.14
  • MDXG $7.99
  • Average True Range (ATR)
  • HLIT 0.33
  • MDXG 0.37
  • MACD
  • HLIT -0.08
  • MDXG 0.04
  • Stochastic Oscillator
  • HLIT 32.93
  • MDXG 58.29

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: